GB0310986D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0310986D0
GB0310986D0 GBGB0310986.5A GB0310986A GB0310986D0 GB 0310986 D0 GB0310986 D0 GB 0310986D0 GB 0310986 A GB0310986 A GB 0310986A GB 0310986 D0 GB0310986 D0 GB 0310986D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0310986.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidelta doo
Original Assignee
Glaxo Group Ltd
Pliva Farmaceutika dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Farmaceutika dd filed Critical Glaxo Group Ltd
Priority to GBGB0310986.5A priority Critical patent/GB0310986D0/en
Publication of GB0310986D0 publication Critical patent/GB0310986D0/en
Priority to PCT/EP2004/005082 priority patent/WO2004101586A1/en
Priority to RU2005134908/04A priority patent/RU2005134908A/ru
Priority to KR1020057021593A priority patent/KR20060026407A/ko
Priority to ES04732102T priority patent/ES2273255T3/es
Priority to ARP040101614A priority patent/AR044309A1/es
Priority to MXPA05012163A priority patent/MXPA05012163A/es
Priority to PL04732102T priority patent/PL1628988T3/pl
Priority to CL200401010A priority patent/CL2004001010A1/es
Priority to JP2006529794A priority patent/JP2007502313A/ja
Priority to HR20060448T priority patent/HRP20060448T3/xx
Priority to PT04732102T priority patent/PT1628988E/pt
Priority to BRPI0410246-0A priority patent/BRPI0410246A/pt
Priority to CA002525452A priority patent/CA2525452A1/en
Priority to AT04732102T priority patent/ATE341560T1/de
Priority to US10/556,645 priority patent/US7569550B2/en
Priority to EP04732102A priority patent/EP1628988B1/en
Priority to AU2004238528A priority patent/AU2004238528A1/en
Priority to DK04732102T priority patent/DK1628988T3/da
Priority to SI200430114T priority patent/SI1628988T1/sl
Priority to CNA2004800192646A priority patent/CN1849328A/zh
Priority to DE602004002696T priority patent/DE602004002696T2/de
Priority to ZA200509079A priority patent/ZA200509079B/xx
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GBGB0310986.5A 2003-05-13 2003-05-13 Novel compounds Ceased GB0310986D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GBGB0310986.5A GB0310986D0 (en) 2003-05-13 2003-05-13 Novel compounds
DE602004002696T DE602004002696T2 (de) 2003-05-13 2004-05-11 Neue 14- und 15-gliedrige ringverbindungen
HR20060448T HRP20060448T3 (hr) 2003-05-13 2004-05-11 Novi spojevi s 14 i 15-članim prstenovima
BRPI0410246-0A BRPI0410246A (pt) 2003-05-13 2004-05-11 composto, processo para a preparação de um composto, uso de um composto, método para o tratamento do corpo humano ou de animal não humano para combater infecção microbiana, e, composição farmacêutica
KR1020057021593A KR20060026407A (ko) 2003-05-13 2004-05-11 14원 및 15원 고리 화합물
ES04732102T ES2273255T3 (es) 2003-05-13 2004-05-11 Nuevos compuestos ciclicos de 14 y 15 miembros.
ARP040101614A AR044309A1 (es) 2003-05-13 2004-05-11 Compuesto de macrolido de 14 y 15 miembros sustituido en la posicion 4", procedimiento para la preparacion del mismo, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende
MXPA05012163A MXPA05012163A (es) 2003-05-13 2004-05-11 Compuestos novedosos de anillo de 14 y 15 miembros.
PL04732102T PL1628988T3 (pl) 2003-05-13 2004-05-11 Nowe 14- i 15-członowe pierścieniowe związki
CL200401010A CL2004001010A1 (es) 2003-05-13 2004-05-11 Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica
JP2006529794A JP2007502313A (ja) 2003-05-13 2004-05-11 新規１４及び１５員環化合物
PCT/EP2004/005082 WO2004101586A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 membered-ring compounds
PT04732102T PT1628988E (pt) 2003-05-13 2004-05-11 Novos compostos em anel de 14 e 15 membros
RU2005134908/04A RU2005134908A (ru) 2003-05-13 2004-05-11 Новые соединения с 14- и 15-членными кольцами
CA002525452A CA2525452A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 membered-ring compounds
AT04732102T ATE341560T1 (de) 2003-05-13 2004-05-11 Neue 14- und 15-gliedrige ringverbindungen
US10/556,645 US7569550B2 (en) 2003-05-13 2004-05-11 14 and 15 membered ring compounds
EP04732102A EP1628988B1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 membered-ring compounds
AU2004238528A AU2004238528A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 membered-ring compounds
DK04732102T DK1628988T3 (da) 2003-05-13 2004-05-11 Hidtil ukendte 14- og 15 leddede ringforbindelser
SI200430114T SI1628988T1 (sl) 2003-05-13 2004-05-11 Nove 14- in 15-clenske obrocne spojine
CNA2004800192646A CN1849328A (zh) 2003-05-13 2004-05-11 新型14和15元环化合物
ZA200509079A ZA200509079B (en) 2003-05-13 2005-11-09 Novel 14 and 15 membered-ring compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0310986.5A GB0310986D0 (en) 2003-05-13 2003-05-13 Novel compounds

Publications (1)

Publication Number Publication Date
GB0310986D0 true GB0310986D0 (en) 2003-06-18

Family

ID=9957984

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0310986.5A Ceased GB0310986D0 (en) 2003-05-13 2003-05-13 Novel compounds

Country Status (22)

Country Link
US (1) US7569550B2 (enExample)
EP (1) EP1628988B1 (enExample)
JP (1) JP2007502313A (enExample)
KR (1) KR20060026407A (enExample)
CN (1) CN1849328A (enExample)
AR (1) AR044309A1 (enExample)
AT (1) ATE341560T1 (enExample)
AU (1) AU2004238528A1 (enExample)
BR (1) BRPI0410246A (enExample)
CA (1) CA2525452A1 (enExample)
CL (1) CL2004001010A1 (enExample)
DE (1) DE602004002696T2 (enExample)
DK (1) DK1628988T3 (enExample)
ES (1) ES2273255T3 (enExample)
GB (1) GB0310986D0 (enExample)
HR (1) HRP20060448T3 (enExample)
MX (1) MXPA05012163A (enExample)
PL (1) PL1628988T3 (enExample)
PT (1) PT1628988E (enExample)
RU (1) RU2005134908A (enExample)
WO (1) WO2004101586A1 (enExample)
ZA (1) ZA200509079B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007054295A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited New 4*-substituted erythromycin derivative
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
US8080529B2 (en) 2005-01-13 2011-12-20 Glaxo Group Limited Macrolides with anti-inflammatory activity
JP2008540503A (ja) 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用なエーテル結合マクロライド
WO2007054296A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited Macrolones
MX2011008074A (es) 2009-01-30 2011-08-17 Glaxo Group Ltd Macrolido anti-inflamatorio.
CN111574575B (zh) * 2020-04-29 2022-05-17 北京理工大学 一种含有大环内酯基的喹喏酮衍生物、制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465581B1 (en) * 1989-03-28 1995-10-04 Abbott Laboratories Erythromycin derivatives
AU3710695A (en) * 1995-04-27 1996-11-18 Laboratorios Aranda, S.A. De C.V. Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them
AU710532B2 (en) * 1996-05-07 1999-09-23 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
JP4311203B2 (ja) * 2001-08-08 2009-08-12 大正製薬株式会社 １１ａ−アザライド化合物及びその製造方法
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
AR044309A1 (es) 2005-09-07
US7569550B2 (en) 2009-08-04
US20070185117A1 (en) 2007-08-09
DE602004002696T2 (de) 2007-08-16
RU2005134908A (ru) 2006-06-27
WO2004101586A1 (en) 2004-11-25
PT1628988E (pt) 2007-01-31
BRPI0410246A (pt) 2006-05-16
PL1628988T3 (pl) 2007-03-30
ES2273255T3 (es) 2007-05-01
ZA200509079B (en) 2007-02-28
CA2525452A1 (en) 2004-11-25
KR20060026407A (ko) 2006-03-23
JP2007502313A (ja) 2007-02-08
ATE341560T1 (de) 2006-10-15
EP1628988A1 (en) 2006-03-01
MXPA05012163A (es) 2006-05-19
CN1849328A (zh) 2006-10-18
CL2004001010A1 (es) 2005-03-18
DE602004002696D1 (de) 2006-11-16
DK1628988T3 (da) 2007-02-05
AU2004238528A1 (en) 2004-11-25
EP1628988B1 (en) 2006-10-04
HRP20060448T3 (hr) 2007-03-31

Similar Documents

Publication Publication Date Title
GB0308114D0 (en) Novel compounds
GB0305918D0 (en) Novel compounds
GB0308186D0 (en) Novel compounds
GB0308185D0 (en) Novel compounds
GB0308333D0 (en) Novel compounds
GB0304424D0 (en) Novel compounds
EP1596860A4 (en) NEW CONNECTIONS
GB0310986D0 (en) Novel compounds
GB0305426D0 (en) Novel compounds
GB0302431D0 (en) Novel compounds
GB0304809D0 (en) Novel compounds
GB0302546D0 (en) Novel compounds
GB0304802D0 (en) Novel compounds
GB0308187D0 (en) Novel compounds
GB0305722D0 (en) Novel compounds
GB0305688D0 (en) Novel compounds
GB0305687D0 (en) Novel compounds
GB0305586D0 (en) Novel compounds
GB0305564D0 (en) Novel compounds
GB0306213D0 (en) Novel compounds
GB0305293D0 (en) Novel compounds
GB0304408D0 (en) Novel compounds
GB0305291D0 (en) Novel compounds
GB0305290D0 (en) Novel compounds
GB0305285D0 (en) Novel compounds

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: PLIVA-ISTRAZIVACKI INSTITUT D.O.O.

Free format text: FORMER APPLICANT(S): PLIVA D.D.

AT Applications terminated before publication under section 16(1)